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ABSTRACT 
There is a lack of evidence-based interventions for patients with persisting problems after 
mild traumatic brain injury (mTBI). The interventions needed should focus on patients at 
particular risk for persisting disability after mTBI and target modifiable factors. After initial 
studies of an early educational intervention unexpectedly gave negative results (studies I, II), 
a renewed focus on possible targets for interventions was needed: studies III, IV explored 
associations with self-reported and objectively measured visual disturbances, self-rated and 
objectively measured fatigue, and correlations between fatigue, visual functions and attention. 
Study design and participants: Randomized controlled intervention study (studies I, II), and 
exploratory prospective observational study (studies III, IV). In studies I, II, patients with an 
estimated high risk for persisting disability were randomized to an early interventional visit 
(EIV) to physician or to Treatment as usual (TAU). All 173 patients, including the non-
randomized group were followed up at 3 months after the injury. Studies III, IV, compared 
patients with mTBI to patients with minor orthopedic trauma and non-injured controls, with 
15 in each group. Participants were assessed sub-acutely and after approximately 3 months. 
Outcome measures: Multimodal outcome measures related to the ICF-framework 
incorporating: 1.Self-reported data on symptoms (Rivermead Post Concussion Symptoms 
Questionnaire (RPQ)), activity and participation (Occupational Gap Questionnaire, 
Rivermead Head Injury Follow-up Questionnaire), and quality of life (SF-36) (studies I, II). 
2. Findings from visual examination (accommodation, convergence, visual acuity, saccades), 
and visual symptoms (Convergence Insufficiency Symptoms Survey (CISS) and RPQ (study 
III). 3. Self- reported data on fatigue: acquired fatigue, (RPQ-f), and trait fatigue (Fatigue 
Severity Scale) and objectively measured cognitive fatigability (DSST-f) and saccades (study 
IV). 
Results: The intervention was not found to have an effect on symptoms, activity, 
participation or quality of life (studies I, II). Patients with few symptoms early after the mTBI 
continued to report few problems at follow-up. Visual findings showed that accommodative 
amplitude was lower in the mTBI group compared to non-injured controls at sub-acute stage; 
near point of convergence in the mTBI group was receded at sub-acute stage, but improved at 
follow-up; patients with mTBI reported a higher CISS score than persons in the control 
groups (study III). Acquired fatigue was present more often after mTBI and correlated to 
cognitive fatigability. Associations were found between acquired fatigue and some saccade 
measures, but not with other visual measures. 
Conclusions: An early intervention to patients at risk for persisting disability had no effect on 
symptoms, activity, participation or quality of life. Patients with few symptoms early after 
mTBI are likely to have a good outcome. Some transient measurable visual changes 
regarding convergence were found in patients with mTBI during the sub-acute period after 
the injury. Some support for the suggested value of assessing different aspects of fatigue have 
been found. 
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1 INTRODUCTION 
Head injury can happen to anyone at any time, resulting in traumatic brain injury (TBI) of 
varying severity. TBI is a substantial public health problem and is one of the most common 
neurological conditions that affect functioning of people of working age (1). Traumatic brain 
injury is categorized into mild, moderate and severe according to the scores of Glasgow 
Coma Scale (2). Generally, traumatic brain injury is classified as severe, if GCS score is 8 or 
less, moderate if GCS score is 9-12, and mild if the GCS is 13-15. The largest part, 70 - 90% 
of traumatic brain injuries are mild (3). Prognosis for mild traumatic brain injury (mTBI) is 
often good (4), but a minority of patients report long lasting problems (5-12) and the clinical 
course and outcomes are variable. Given the high incidence of mTBI, even a small proportion 
of patients with persisting symptoms and disability after mTBI represents a large number of 
people. The long-term consequences involve both individual suffering and increased costs for 
society, primarily by means of increased consumption of health care (13). Interventions after 
mTBI should target those patients that are at risk for persistent symptoms (14). 
Despite growing evidence from mTBI research, there is still a lack of knowledge in 
prediction, prognosis and treatment of this heterogeneous condition. Therefore, the search is 
ongoing for objective methods for assessment and monitoring recovery after mTBI. 
1.1 DEFINITION OF MILD TRAUMATIC BRAIN INJURY 
There is variety of criteria used to define mTBI (15, 16). World Health Organization (WHO) 
Collaborating Center Task Force on Mild Traumatic Brain Injury have recommended a 
definition of mTBI for research use (17), that is based on the definition provided by Mild 
Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest 
Group of the American Congress of Rehabilitation Medicine (ACRM) (18): “mTBI is an 
acute brain injury resulting from mechanical energy to the head from external physical forces. 
Operational criteria for clinical identification include: (i) 1 or more of the following: 
confusion or disorientation, loss of consciousness for 30 minutes or less, post-traumatic 
amnesia for less than 24 hours, and/or other transient neurological abnormalities such as focal 
signs, seizure, and intracranial lesion not requiring surgery; (ii) Glasgow Coma Scale score of 
13–15 after 30 minutes post-injury or later upon presentation for healthcare. These 
manifestations of mTBI must not be due to drugs, alcohol, medications, caused by other 
injuries or treatment for other injuries (e.g. systemic injuries, facial injuries or intubation), 
caused by other problems (e.g. psychological trauma, language barrier or coexisting medical 
conditions) or caused by a penetrating craniocerebral injury” (17). 
Most of the patients with mTBI do not have visible abnormalities on neuroimaging (19). 
Prevalence of neuroradiological abnormalities, such as, bleeding or swelling is estimated 
according to GCS, ranging from 5% for those with GCS 15 to 30% with GCS 13 (20). 
Most mTBI research is conducted in civilian population, but there are two other related mTBI 
research areas: sports-related concussion (21) and mTBI caused by the exposure of military 
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personnel to blasts (22). Terminology related to mild head trauma is diverse, and the terms 
“Mild traumatic brain injury” and “concussion” are used somewhat interchangeably, with 
“concussion” being more often used in relation to sporting injuries. The recent sport related 
concussion conference concluded that “the lessons derived from non-sporting mTBI research 
informs the understanding of sport-related concussion (and vice versa), and this arbitrary 
separation of sporting versus non-sporting TBI should not be viewed as a dichotomous or 
exclusive view of TBI” (21). 
1.2 EPIDEMIOLOGY 
The incidence of hospital treated patients with mTBI in the Western countries is between 100 
to 300 persons per 100,000 inhabitants (3). Most of the mTBI are caused by falls, motor 
vehicle accidents followed by sports injuries (3, 23). In the latest decades, rates of 
hospitalization after mTBI in Sweden are decreasing, from approximately, ~17,000 in 1998 
to ~10,000 in 2008. According to recent statistics report from Swedish National Board of 
Health and Welfare, in 2014-2016, the annual incidence of hospitalization of patients with 
mTBI in Sweden decreased to 6,690 (24). The probable reason for the reduced number of 
hospitalizations after mTBI in Sweden is an introduction in 2006 of the clinical guidelines 
(25) for the routine use of computed tomography scan (CT-scan) examination in diagnosing 
mTBI in acute stage (26). Regarding visits to emergency departments (ED) due to mTBI in 
Sweden, the number of registered visits in 2010 was 21,700 in all age groups (0 to >80 years) 
(27). That comprised 231 persons per 100,000 inhabitants. The highest incidence rates were 
in age groups 0-14 years and > 80 years. Most of the individuals presenting to ED were men 
(27). A considerable number of patients with mTBI are not seeking medical care, and thus, 
are not included in hospital or ED registers, which might imply that the incidence may be 
much higher, up to an estimated 600 persons per 100,000 (3). Consequently, the genuine 
incidence of mTBI is difficult to determine partly due to a lack of the objective diagnostic 
testing, and heterogeneity of definitions of mTBI in the studies (28). 
1.3 MILD TRAUMATIC BRAIN INJURY AND INTERNATIONAL 
CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF) 
The ICF is a classification system, which provides a standardized conceptual basis for 
definition and measurements of functioning and disability (29). The ICF framework includes 
the following components: body structure and functioning, activity and participation, and 
environmental and personal factors (29). Functioning after a disease or injury and disability is 
presented as a complex interaction between health condition, personal factors and 
circumstances surrounding the individual. The ICF concept is a useful tool for measuring the 
consequences of such clinical conditions that do not have established objective measures 
during the recovery, such as mTBI or chronic pain. 
The ICF serves as reference system during all phases of neurorehabilitation: from diagnosis 
setting to the assessment of rehabilitation needs, goal setting, interventions and outcome 
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measuring (30). The ICF can be used in each of these phases in order to create an 
individualized plan for rehabilitation. 
The ICF concept has in a qualitative study by Sveen et al 2013 been found to be useful in 
describing problems related to mTBI (31). This study described that most reported functions 
were related to cognitive and emotional domains of symptoms, frequently reported 
impairment of activities and participation, concerned daily routines and work. Reported 
environmental factors included health care services, social security system, social network 
and attitudes towards injured persons. 
1.4 ASPECTS RELATED TO BODY STRUCTURE AND FUNCTIONING 
1.4.1 Pathophysiological mechanisms 
Impact on the brain of biomechanical force includes linear and rotational acceleration 
components (16, 32). After the impact of biomechanical force to the head, the primary injury 
is induced to the neuronal bodies and axons, often also causing intracranial hemorrhages (33). 
Directly after the primary injury, a cascade of metabolic processes starts causing secondary 
injury (34). The knowledge of biomechanical and neurometabolic processes after TBI is 
mostly based on results from experimental research on animal models (35). As a response to 
metabolic changes, neuroinflammation is initiated (36). Neuroinflammation is thought to 
have both positive and negative components, which are also likely to differ between the acute 
and chronic phase of brain injury (34). Neuroimmunological response to trauma can be seen 
as being beneficial, like a wound healing process, including “cleaning” of the cellular debris, 
restoration of brain tissue homeostasis and preservation of the blood-brain barrier (34). A 
mild acute inflammation is likely to be required for stimulation of neurogenesis, or healing 
(16). At the same time, neuroinflammation that becomes chronic can be disadvantageous for 
the healing process. For most of mTBI cases the neurometabolic changes are reversible (16). 
Biochemical blood tests have been suggested as biomarkers for diagnosing and tracking 
recovery after mTBI. One established biochemical marker is a calcium binding protein S-
100B, found in astroglial cells after mTBI (37). S-100B has, however, a low specificity, due 
to the extracranial release, and has been found in the blood of patients with orthopedic trauma 
(38), and in healthy individuals after sports activities (39). Recently, a combination of two 
biochemical blood biomarkers, glial fibrillary acidic protein (GFAP), found only in astrocytes 
in central nervous system, and ubiquitin C-terminal hydrolase L1 (UCH-L1), found in neuron 
cytoplasm, also expressed in endothelial and smooth muscle cells (40), was recognized as a 
diagnostic test by FDA (Food and drug administration in USA) (41). This test showing high 
sensitivity and specificity, can rule out individuals with a low risk of intracranial injury and 
those who do not need a brain CT-scan (41). 
Dynamic changes in the brain that vary with time after the injury, could be detected by 
diffusion tensor imaging (DTI) demonstrating changes in microstructural integrity of white 
matter tracts (42). Functional magnetic resonance imaging (fMRI) and resting state functional 
MRI (rs-fMRI) detect changes in functional connectivity of the brain networks (43). Recent 
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studies have shown altered activation of brain networks in patients with mTBI (44, 45), and 
some associations with persisting symptoms at 3 months after injury (46). 
1.4.2 Symptoms 
Symptoms after mTBI are often divided into the following groups: somatic (headache, 
dizziness, nausea/vomiting, sleep disturbances, noise sensitivity), cognitive (deficits in 
attention, executive problems, pure memory, taking longer to think) and emotional/affective 
symptoms (emotional instability, irritability, feeling depressed, restlessness). The visual 
symptoms, such as double vision and blurred vision, are often attributed to somatic symptoms 
group. 
Symptoms after mTBI are often regarded as post-concussion symptoms and are categorized 
by two different sets of criteria, both criticized for the lack of specificity to mTBI (4): 
Postconcussional syndrome according to the International Classification of diseases, 10th 
edition (ICD-10) (47) and Postconcussional disorder according to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) (48). In Postconcussional syndrome, a 
history of head trauma with LOC and three symptoms should be included from different 
symptom categories, among others, headache, dizziness, fatigue, irritability, reduced 
tolerance to stress and alcohol, fear of permanent brain damage (47). Postconcussional 
disorder has more stringent criteria and requires head trauma, three of the symptoms that last 
at least 3 months, such as being easily fatigued, headache, dizziness, anxiety, or depression, 
in addition to evidence from neuropsychological assessment of difficulties in concentrations, 
memory and attention, and decline in social and occupational functioning (48). The new 
Diagnostic and Statistical Manual of Mental disorders (DSM-V) does not any longer include 
a category “postconcussional disorder”, and has instead introduced a new category “Major, or 
mild neurocognitive disorder due to traumatic brain injury” (49). 
Although most of the symptoms after mTBI are attributed to the brain injury, most of the 
complaints are non-specific and are also reported after other non-head injuries or chronic pain 
(50), and are even present in the general population (51). Several studies showed that trauma 
controls with injuries other than to the head report similar symptoms to patients with mTBI 
(52, 53). The same symptoms might also occur in many other conditions, without a head 
injury, such as anxiety or depression (54-56). There is no consistent difference between mTBI 
and trauma patients in the sub-acute phase; therefore, it was proposed to replace the term 
post-concussion with post-traumatic (57). However, several longitudinal controlled studies 
showed differences in the frequency and nature of reported complaints between patients with 
mTBI and trauma controls, with more severe complaints in the mTBI group (58-60). A recent 
systematic review of mTBI has suggested that other factors unrelated to injury influence the 
persistence of symptoms: injury-related psychological stress, poor premorbid physical and 
psychiatric health (57). Co-morbidities, such as anxiety at the time of injury and one week 
after the injury have been shown to predict post-concussion symptoms at three months after 
mTBI (52). Personality traits and psychological vulnerability have been suggested to 
contribute to long-term complaints after mTBI (61). Female gender is shown to be a risk 
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factor for long-term symptoms (62-64). Litigation and seeking compensation are also related 
to persistent symptoms (4, 65). 
1.4.3 Specific aspects: vision and fatigue 
Vision 
Visual symptoms are part of self-reported complaints after mTBI, and include double or 
blurred vision, eyestrain, and sensitivity to light. Visual networks are widespread throughout 
the brain, and trauma to the head, as in mTBI, can disrupt integrity of the fragile functional 
network (66-69). Recent studies show associations between findings in assessments of 
oculomotor functions and changes in neuroimaging, both with diffusion tensor imaging (70), 
and with fMRI (68). Vision plays a vital part in connecting people with the surrounding 
world and therefore even minor visual disturbances after mTBI can cause problems in 
everyday activities. Therefore, a sudden change in visual functioning after mTBI might 
impact activities that involve visual tasks requiring efforts and concentration, such as 
computer work or reading, with particular difficulties in following the text line or un-
intentional jumping over a word. 
Previous studies have shown a high prevalence, up to 70%, of various visual changes in 
individuals with visual complaints after mTBI (71-73), compared to less than 10% in the 
otherwise healthy pre-presbyopic population with visual symptoms (74-76). Changes in 
oculomotor-based vision functions, namely, accommodation, convergence and the generation 
of saccades, presented in patients with mTBI both in civilian and military settings (71, 77-79) 
(see Glossary of terms for visual functions and assessments). 
Deficiencies in convergence are the most reported oculomotor changes after mTBI, including 
receded near point of convergence (NPC), and have been shown in retrospective and 
controlled studies (71, 72, 78). Convergence insufficiency (CI) might be one of the reasons 
for visual symptoms after mTBI such as blurred or double vision or impaired work at near 
(73). Reduced fusional vergence, a reduced ability to keep eyes in alignment and maintain 
clear single vision could be another reason for blurred vision after mTBI (80). Another vision 
problem that is found in patients with mTBI is deficits in accommodation with impaired 
focusing at near or at a distance (81, 82). The accommodative abilities generally deteriorate 
with age, and at 40-45 years of age most of the individuals have presbyopia, difficulties in 
focusing on near objects. 
Changes in saccade generation parameters have been shown in several studies (72, 77, 78, 83, 
84). Saccades are fast eye movements elicited to re-fixate from one point to another. There 
are several types of saccades: visually guided saccades, such as prosaccades, rapid eye 
movements towards objects suddenly appearing in the visual field; and volitional saccades, 
such as antisaccades, that involve cognitive processing with inhibition of reflexive response 
and intentional engaging of attention and spatial memory. Previous studies indicate that 
antisaccades might be effective measures to distinguish patients with mTBI from controls, 
indirectly showing cognitive deficits after mTBI (70, 77, 85). 
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Assessment of oculomotor changes has been proposed as a method for diagnosing and 
monitoring the recovery following mTBI and as a possible biomarker after mTBI (70, 86). 
Most of the studies of visual changes after mTBI include patients with visual complaints in 
later stages, several months or years after the mTBI. There are few prospective studies 
investigating relationship between visual complaints and objective assessments of vision 
functioning in acute and sub-acute stage after mTBI (84, 87). 
Glossary of terms related to visual assessments 
 
Fatigue 
Fatigue is not a unitary phenomenon, and no exact definition of fatigue exists (88). Fatigue is 
described as perceived lack of physical and mental energy that interferes with daily activities, 
or a diminished capacity to accomplish an activity (88, 89). Brief periods of fatigue are 
estimated to occur in 15-25% of the general population (90). Fatigue is one of the most 
frequently reported symptoms after mTBI (7-9, 58) and is associated with poor outcome (9, 
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91). Existing evidence shows that self-reported fatigue decreases over time after mTBI, but 
some patients continue reporting persisting fatigue (92). 
Results of self-rating of fatigue have been found to be hampered by confounding from co-
existing problems such as anxiety, depression, sleep disturbances or pain (93, 94). Fatigue has 
also been shown to be associated with reduced psychomotor speed (95) attention function 
(96) and executive functions (97). 
There is a lack of consistency in the definition of fatigue and also the use of different 
assessments for investigating fatigue in mTBI (93). Several different scales have been 
developed for the assessment of fatigue from different perspectives, such as frequency, 
severity, impact on functional outcome, and time period over which the respondents rate their 
fatigue. 
A definition of trait fatigue, or general fatigue is proposed for measuring the extent of 
perceived fatigue over time, and state fatigue, for fatigue at the moment (93). One of the 
scales for measuring trait fatigue is the Fatigue Severity Scale (FSS), assessing general 
fatigue and its consequences on daily functioning during (98). 
In order to introduce an objective fatigue measure, a standardized taxonomy for fatigue was 
proposed, differentiating the perception of fatigue, as a subjective concept, and performance 
fatigability, which could be objectively measured (88). 
Few previous studies have shown the relationship between self-reported fatigue and 
objectively measured cognitive fatigability, e.g. by objectively measuring a decreased 
performance over time during a sustained complex information processing task (93, 99). 
1.5 ACTIVITY AND PARTICIPATION 
According to the International Classification of Functioning, Disability and Health (ICF), 
activity is described as a task or action performed by an individual. Activity limitations are 
difficulties experienced by an individual in performing activities of daily living (29). Studies 
of mTBI have shown that more symptoms early after the injury correlate with more 
symptoms and changes in everyday activities 3 months after the injury (7, 12). Moreover, 
patients with perceived cognitive deficits after mTBI have been found to experience 
limitations in their daily activities (58). Long lasting symptoms after mTBI might contribute 
to the limitations in the person’s social, recreational life, and work disability (5, 100). One of 
the goals of rehabilitation is participation, defined as person’s involvement in a life situation 
(29), sometimes even despite the fact that there are long-lasting symptoms due to an injury or 
disease. Restrictions in participation might lead to life that is less diverse (101). 
1.5.1 Sickness absence 
International Classification of Functioning, Disability and Health had emphasized that work 
performance and return to work are very important outcome measures and key elements in 
rehabilitation (29). Studies of sickness absence and return to work after mTBI are few and 
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have reported divergent results (4, 102). The varying results of these studies might be due to 
differences in mTBI definition and in patient selection and characteristics (102). Existing 
evidence shows that most of the individuals return to previous occupations 3-6 months after 
the injury (7, 102-104). Sickness absence of less than two weeks in more than 50% of 
patients with mTBI was reported in a Finnish study that included 109 patients (104). The 
majority of them, 93%, ended their sick leave within 3 months. In one Swedish study, 75% of 
patients with mTBI had a sickness absence length of less than 10 days, 20% of patients were 
on sick leave up to 30 days, and only one person did not return to work three months after the 
injury (7). Another Swedish study revealed that 15% of patients with mTBI still were on sick 
leave one year after mTBI (105). Previous studies showed that patients with mTBI reported 
greater effort and more fatigue related to return to work after the injury (106) compared to a 
trauma control group. However, rates of patients with mTBI that returned to work did not 
show a difference from a trauma control group (58). 
1.6 PERSONAL FACTORS 
Mild traumatic brain injury is a traumatic event for the person sustaining the injury, 
indicating that there is a psychological distress involved. Persisting symptoms after mTBI are 
difficult to compare between individual patients despite the similar severity and injury 
mechanisms (11). Given the importance of distinguishing those patients at risk for persistent 
complaints, vulnerability to traumatic events can be a factor to consider (107). 
One of the factors influencing response to traumatic events that has been suggested is 
psychological coping, e.g. psychological adaptation to stress or important life events (108). 
There are different strategies of coping – active, e.g. problem-solving, and passive, or 
maladaptive, which is associated with negative emotions such as worrying (108). A negative 
illness perception in combination with maladaptive coping strategy might lead to anxiety and 
depression, and in that way, sustain post-concussion symptoms (61, 109, 110). 
1.7 QUALITY OF LIFE 
The WHO describes quality of life of each individual as “perception of ones position in life in 
the context of the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns” (111). 
Health-related quality of life (QoL) lies outside the ICF framework, but plays an important 
part in the comprehensive assessment of patients with mTBI (61, 109). Health- related QoL 
instruments measure different dimensions, such as physical, psychological, social and daily 
life (112). The instruments used in assessment of activity and participation overlap partially 
with health-related QoL measures (113). The latter, however provide an important extra 
dimension in assessing the subjective experience of a person’s problems and the degree to 
which they are bothered by the problems (113). 
In previous studies, reduced quality of life correlated with a high number of post-concussion 
symptoms 3 months after injury (100). Quality of life and emotional functioning after mTBI 
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were shown to be associated with pre-injury coping styles (109). Patients with mTBI with 
avoidant coping strategies had worse emotional functioning and reported a lower QoL (109). 
1.8 TOWARDS HOLISTIC APPROACH: BIOPSYCHOSOCIAL MODEL 
In order to understand persisting symptoms and poor outcome after mTBI, one has to take 
into account multiple biological, psychological and social factors that influence the recovery 
process. A biopsychosocial model is proposed as a concept for poor outcome after mTBI 
comprising pre-, peri, and post-injury factors influencing recovery after mTBI (114). 
Reporting of post-concussion symptoms depends on the individual, and represents an 
accumulation of a myriad of variables, such as current life stress, genetics, personality 
factors, history of mental health and other medical problems as well as different psychosocial 
factors. 
The biopsychosocial approach can help to guide clinical management in ruling out alternative 
diagnoses and explanations for persisting problems (114, 115). This includes careful 
documentation of the nature and course of symptoms, the history of previous medical 
conditions and mood disorders, clinical examination neurological domains, cognition and 
vision and an estimation of potential influencing factors, such as psychosocial situation, 
malingering, secondary gain (116). Clinical recommendations that include the 
biopsychosocial approach might help to guide clinicians towards the right areas of 
interventions for persisting problems after mTBI. 
1.9 CLINICAL COURSE 
1.9.1 Recovery after brain injury in general 
Recovery from a traumatic brain injury in general varies depending on the individual and on 
the type and severity of brain injury. Patients can have impairments in physical, cognitive and 
emotional functioning as a consequence of the injury. Attempts at predicting the degree of 
TBI recovery remain crude. Recovery can be seen months, and even years, after the initial 
injury. Some indicators of prognosis after TBI are considered to be important: duration of 
coma or loss of consciousness, duration of post-traumatic amnesia, GCS and age (117). 
There are some prediction models that have been suggested as being useful in clinical 
practice. One of these is the CRASH model for moderate and severe TBI (117), that estimates 
the risk of mortality at 14 days and death/severe disability at six months after the injury based 
on country, age, GCS score, pupils reaction to light, major extra-cranial injury and CT-scan 
findings. 
Recovery of brain function is thought to occur by several neuroplastic mechanisms (118, 
119). Some neuroplastic mechanisms are activated early after the injury, and some continue 
their effect even in the chronic stage (120). Neuroplasticity also plays an important role in the 
re-learning of lost skills or in acquiring new compensatory skills (119). Understanding the 
natural course of recovery and neuroplastic mechanisms after TBI is important for planning 
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interventions (120). The natural history of recovery after brain injury can help to navigate 
between the problems that are known to be resolved naturally (initial confusion, pain), and 
possible complications (hydrocephalus) (115). 
1.9.2 Clinical course of mild traumatic brain injury 
Despite extensive research in neurophysiology, biomechanics and clinical presentation, there 
are still gaps in our understanding of the course of recovery after mTBI. One of the possible 
explanations could be that there are no established objective measures correlating with 
symptom presentation and limitations in daily activities. The systematic review by the 
International Collaboration on Mild Traumatic Brain Injury on self-reported prognosis after 
mTBI 2014, a follow-up of the WHO taskforce 2004, concluded that symptoms reported after 
mTBI are mostly transient and are resolved within days to weeks after the injury, and most of 
patients recover over one year (4, 57). 
Cognitive impairment has been found to be common up to 2 weeks after mTBI, with a rapid 
improvement (52, 121). A meta-analysis and prospective studies on cognitive functioning 
after mTBI concluded that patients with mTBI have no longer impact on global cognitive 
functioning at 90 days after mTBI (19, 122). 
There are no established phases during the time of recovery after mTBI. Studies of mTBI 
report an outcome at different time periods after the injury: 2-3 weeks, 1, 3 or 6 months after 
mTBI. Generally, time period of one to three days after mTBI is called acute phase; some 
studies define even 1 week as acute post-injury phase after mTBI (6, 123). The time period 
up to 3 weeks or one month is defined as sub-acute phase and thereafter – the chronic phase. 
Objective assessment of patients with mTBI is important both at the proximal and at the 
distant end of the recovery process (116). 
Monitoring the recovery after mTBI is based extensively on self-reported injury events and 
post-injury symptoms. Several potential biases and confounders during the recovery should 
be accounted for after mTBI: imprecise recall of duration of loss of consciousness (LOC) or 
post-traumatic amnesia (PTA) and injury severity; the impact of acute stress on symptom 
reporting; influence of comorbid conditions, such as pain and substance abuse; inaccurate 
self-estimation of pre-injury functioning, psychosocial considerations that arise after the 
injury and that are automatically self-attributed to mTBI; the influence of comorbid 
conditions such as anxiety or depression (28, 124). 
1.10 CLINICAL MANAGEMENT OF MILD TRAUMATIC BRAIN INJURY 
1.10.1 Acute management 
The most important issue in the early management of mTBI is to recognize neurological 
symptoms and signs that increase the risk of acute deterioration. 
There are two major complications after mTBI: delayed hemorrhage and delayed swelling of 
the brain. Initial examination and decision-making about the severity of brain injury 
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according to GCS might be compromised by intoxication with alcohol or drugs. Neurological 
signs, such as pupillary response to light, and brain imaging are not sensitive to intoxication 
(42, 125). Common structural imaging methods for mTBI are CT-scan, performed acute, on 
the day of the injury, and MRI, usually performed sub-acute, up to 3 weeks after the injury. 
MRI has shown intracranial changes, such as hemorrhages and axonal injuries in 27% of the 
patients with mTBI, despite normal acute CT-scan on admission (42). 
In order to improve neurotrauma care, the evidence-based Scandinavian guidelines for initial 
management of minimal, mild and moderate head injury for adult patients were updated 
including CT-scan selection, admission and discharge (126). Patients presenting with GCS 13 
are regarded here as patients with moderate traumatic brain injury. These patients have to 
undergo a CT-scan, they have to be admitted for observation, and a physician has to consider 
consultation with a neurosurgeon. The same recommendations apply to patients presenting 
with GCS 14-15 and having additional risk factors, such as post-traumatic seizures, 
neurological deficits or treatment with anticoagulants. Patients with GCS 14 and 15 with no 
risk factors and serum biomarker S100B ≤ 0.1 within 6 hours after the injury could be 
discharged home. A new category, minimal traumatic brain injury, is introduced defining 
patients presenting at ED with GCS 15 and no additional risk factors that could mean a 
discharged home. It is recommended to provide all patients with written information at 
discharge (126). 
1.10.2 Interventions later after injury 
Given the generally good recovery after mTBI, it is suggested that follow-up should focus on 
those patients who have a high risk for a poor outcome (14). Interventions after mTBI are 
facing two important challenges: to identify patients at risk early after the injury in order to 
prevent chronification of complaints, and to identify targets, e.g. prognostic modifiable risk 
factors, for poor outcome that are important for secondary prevention, aiming to address 
persisting symptoms and improving outcome (114). 
The existing evidence, presented in systematic reviews, shows that an early intervention that 
includes educational and reassuring information is beneficial to recovery after mTBI (14, 
127, 128). 
Written information about mTBI and scheduled telephone calls with structured individualized 
educational information at 2 days and at 2, 4, 8, and 12 weeks after the injury gave a 
reduction in post-concussion symptoms at 6 months compared to the control group (129). No 
difference between the groups was found regarding general health. 
A different approach on structured information has been investigated in a study where short 
text messages were sent 3 times daily to patients with mTBI during a period of 1 to 14 days 
after discharge from ED (130). Patients with mTBI showed improvement with fewer and less 
severe post-concussion symptoms, but no statistically significant difference was found 
compared to controls at two weeks after the injury (130). A recent randomized controlled 
interventional study used another novel approach, such as web-based information provided 
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for patients with mTBI in a military setting, and found no difference between intervention 
and controls groups (131). 
Multidisciplinary outpatient interventions have not given any improvement in outcomes (105, 
132, 133).  In a recent randomized controlled trial (RCT), an intervention consisting an 
outpatient follow-up program was offered to the group of patients with persisting symptoms 
6-8 weeks after mTBI compared to a control group that was followed-up by a general 
practitioner (133). This intervention had no effect on return to work, but it was a trend for 
improvement regarding post-concussion symptoms in the intervention group. 
Clinicians have to rule out alternative medical conditions and explanations that may account 
for long-lasting problems after mTBI. Recent studies of mTBI indicate that psychological and 
psychiatric conditions, closely related to post-concussion symptoms, might be targets for 
treatment in order to improve the outcome after the injury. Psychological interventions, such 
as cognitive behavioral therapy (CBT) have been addressed as treatment for patients with 
mTBI (134, 135). A recent randomized controlled trial compared CBT to telephone 
counseling targeting patients with many symptoms early after mTBI (136). Patients were not 
presented with written information. Treatments started 4-6-weeks after mTBI and included 
five sessions of CBT intervention or five phone consultations in time period between 4 and 8-
10 weeks after the injury. Patients in the telephone counseling group had fewer symptoms at 
3 and 12 months after the injury, and more patients in this group showed a full recovery, 
according to the Glasgow Outcome Scale Extended (GOSE) compared to patients who 
received CBT (136). 
The benefit of bed rest early after mTBI has been investigated in an RCT. No effect was 
found of full bed rest during the first 6 days after mTBI and, following a return to full 
activity, gradually from day 7 to day 11 after the injury, compared to a control group of 
patients with mTBI who were restricted to short bed time rest during the day while being 
fully mobile from the first day after the injury (137). 
There is no systematic follow-up after mTBI in Sweden, which is why patients with 
persisting symptoms are often “non-systematically referred to various medical specialties 
with varying competency” (26). A large prospective observational study of 1151 patients 
with mTBI recruited from ED showed that, in a period of six months, almost half of patients 
visited a neurologist, and 10% consulted a psychiatrist/psychologist at the outpatient clinic 
(13). 
There are few studies of pharmacological treatments targeting comorbidities after mTBI such 
as anxiety and depression. Usually, serotonin re-uptake inhibitors (SSRI) are the treatment of 
choice. Treatment with SSRI has shown an improvement in mood, psychological distress and 
cognition, in addition to treating depression and anxiety after mTBI (138, 139). 
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2 AIMS 
The overall aim of the thesis was to evaluate the effect of an early intervention in patients at 
risk for persisting problems after mild traumatic brain injury and to explore potentially 
treatable factors. 
Specific aims were: 
 To compare the effect of an early individualized educational follow-up visit offered 
to patients with many symptoms early after mTBI with the effect of standard care 
regarding symptom load, activity, participation, quality of life and sickness absence 
at three months after mTBI (Studies I and II). 
 To verify the hypothesis based on previous findings that patients reporting no or few 
symptoms early after mTBI, have a good outcome, and thus have low risk for 
persisting disability and no need for routine follow-up (Studies I and II). 
 To explore the occurrence and course of visuomotor disturbance by use of objective 
measures after mTBI, orthopedic injuries and in non-injured controls, and whether 
objectively demonstrated disturbances correlate with self-reported visual symptoms 
after mTBI (Study III). 
 To explore whether self-rated fatigue is more pronounced in patients with mTBI than 
in controls, whether self-rated fatigue is associated with cognitive fatigability, and 
how fatigue correlates with visual functions and attention (Study IV). 
 
3 METHODS 
3.1 STUDY PROTOCOL 
Studies I and II 
Data collection 
Eligible study participants received written information about mTBI along with information 
about the study from the study coordinators or from personnel at the ED. Study coordinators 
informed the staff of the ED at all participating hospitals on several occasions about the study 
and the recruitment procedure. Informed consent from the patients was obtained on their 
discharge from the ED or at the earliest convenience after discharge. 
The written information about mTBI included a description of common symptoms and the 
natural course of recovery. The vast majority of the study population was discharged home 
from the ED in accordance with then current clinical guidelines in Sweden regarding mTBI. 
Some study participants were observed in the ED or on a ward for varying time periods but 
data regarding this were not systematically collected. 
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The following clinical data were recorded at the ED: mechanism of the injury, duration of 
loss of consciousness and/or PTA. A computer tomography scan (CT-scan) was performed if 
judged to be clinically necessary. 
Studies I and II are based on the randomized controlled intervention study that was designed 
in agreement with criteria of Consolidated Standards of Reporting Trials (CONSORT) (140). 
Randomization procedure 
Ten days after the injury, all patients included reported current symptoms by completing the 
Rivermead Post Concussion Symptoms Questionnaire (RPQ) (141). Those patients who 
reported three or more symptoms at the severity levels mild, moderate or severe, i.e. scores 2-
4 on the RPQ, were identified as patients with a high risk for persisting problems. 97 patients 
fulfilling the high-risk criterion were randomized to either to an early intervention visit (EIV) 
or treatment as usual (TAU). Randomization was centralized and performed by the research 
coordinator according to an independently generated random allocation sequence in blocks of 
four. Physicians, specialists in rehabilitation medicine, conducting the intervention were 
blinded to the randomization procedure. 
48 patients were randomized to the EIV group, and 49 patients were randomized to the TAU 
group. Seventy-six patients that reported no or up to 2 symptoms on RPQ (score 0-2) at 10 
days post-injury did not fulfill the symptoms criteria for randomization and were defined as 
low risk patients. 
Blinding 
The data collector (GM) and statistician were blinded to group affiliation. 
Intervention 
At 14-21 days after the injury, the physician, a specialist in rehabilitation medicine, provided 
all patients in the intervention group with a structured early intervention. Interventions at 
different study sites were administered by the rigorous protocol. 
The early educational intervention visit included: 
- A detailed interview about current symptoms and performance in everyday activities, about 
psychosocial circumstances and occupation, about prior and on-going other somatic and 
psychiatric disorders and treatments; 
- Clinical screening for depression and anxiety including using the Hospital Anxiety and 
Depression Scale (HADS) (142); 
- A thorough standard medical examination including neurological examination; 
- Information about symptoms and the natural course of recovery after mTBI; reassurance 
about the good outcome; recommendations about a gradual return to usual everyday activities 
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and strategies if symptoms persist. Information provided during the early intervention was in 
addition to the information about the study and about mTBI received at discharge. 
- Interventions for identified problems related to the mTBI or to comorbidities were provided 
as needed, such as prescription of drugs for pain, anxiety or depression or referral to other 
specialists or teams. 
Treatment as usual (TAU) 
Treatment as usual could comprise a contact with health care providers according to local 
routines, for example, visit to a general practitioner, but no routine follow–up was planned in 
this study. Standardized written information at discharge from the ED or hospital about 
symptoms and outcome after mTBI was provided to all patients in the study and thus also a 
part of the treatment as usual. 
Baseline assessments 
At the baseline, 10 days after mTBI, all patients included reported symptoms in the RPQ; 
limitations in activity and restrictions in participation were reported in the Occupation Gaps 
Questionnaire (OGQ) (143). 
Outcome assessments 
At follow-up 3 months after mTBI, patients reported symptoms on the RPQ and HADS 
(Study I). Limitations in activity and restrictions in participation at follow-up were reported 
on the Rivermead Head Injury Follow-Up Questionnaire (RHFUQ) (144) and on the OGQ, 
and health-related quality of life was reported on the Short-Form 36 (SF-36) (145, 146) 
(Study II). Since the OGQ was completed twice, 10 days and 3 months after the injury, 
changes in perceived gaps could be analyzed. 
Data on sick leave and disability pension 6 months before mTBI and 12 months after the 
injury were collected from the Swedish Social Insurance Agency (Study II). At follow-up, all 
patients were asked to report any contact with healthcare providers. 
Studies III and IV 
Studies III and IV are parts of an exploratory prospective observational study that was 
undertaken between January 2015 and January 2016. 
Inclusion procedure 
The study coordinators checked the medical records daily at the ED. Patients with mTBI and 
minor orthopedic trauma who fulfilled inclusion and exclusion criteria were approached at 
ED or, if discharged, were contacted by phone within 1-3 days after the injury. All study 
participants received written information about the study. At follow-up, some of the patients 
were reminded about the follow-up by phone or email. 
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Data collection 
Injury-related information was collected from hospital records, including injury severity 
characteristics such as GCS on arrival at the ED, loss of consciousness (LOC) and duration of 
the post-traumatic amnesia (PTA), mechanism of the mTBI, results of the imaging with 
computer tomography of the brain. Demographic characteristics including education, 
employment status and on-going studies and medical history were collected by interview with 
all study participants at the baseline examination. 
Initial planning of two visual and neuropsychological assessments at 7-10 days after the 
injury and at follow-up, 75-100 days after the injury, was adjusted in order to increase 
participation and minimize dropouts. The median time between injury and baseline visual 
assessment was 7 days (ranging from 4 to 13 days) for patients with mTBI, and 8 days, 
(range 7-12 days) for orthopedic controls. The median time between injury and follow-up 
visual assessment was 103 days (range 81-232) for patients with mTBI, and 108.5 days 
(range 87-322) for orthopedic controls. Neuropsychological assessment, visual examination 
and structural and resting state functional magnetic resonance imaging (MRI) were 
performed at different times on the same day or at adjacent days. 
No statistically significant difference was found between patients with mTBI and the 
orthopedic control group regarding time between the injury and two assessments, at baseline 
and at follow-up. 
The participants of the study were offered a small gift token. 
3.2 POWER CALCULATION 
Studies I and II 
Power calculation was based on a previous study on patients with mTBI with treatment as 
usual (7). No statistically significant change over time in symptoms intensity, i.e. the sum of 
symptoms according to RPQ, was found in a high-risk group (mean at day 7 = 27.2, SD = 
16.4 vs. mean at 3 months = 27.1, SD = 14.6). Power calculation in this study, accordingly, 
was based on an expected 50% decrease in symptom intensity of 13.5 points (SD = 15) in the 
intervention group, and no change in the control group with a power of 85% and a 
significance level of 5%. The expected difference in change of symptom intensity was equal 
to an effect size of 0.90 to meet these conditions, 24 patients were required in each group. 
With an expected attrition rate of 25%, 32 patients had to be included in each group. 
Studies III and IV 
A power of the study was calculated based on an incidence of 70% in the mTBI group in the 
previous studies on visual disturbances (71-73) and 10% in the control group (74-76). 10 
persons per group were needed in order to detect visual disturbances with 80% power at 
alpha 0.05. To compensate the calculated attrition rate of 30%, 15 persons were enrolled in 
each group. 
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3.3 ETHICS APPROVAL 
Studies I and II 
The regional ethical review board in Stockholm approved the study, diary number 
2007/299/1. The study adhered to the tenets of the Helsinki Declaration. All study patients 
received written information about the study and gave their written informed consent. 
Studies III and IV 
Ethics approval was obtained from the Regional ethical review board in Stockholm, diary 
number 2014/597-31/1. The study adhered to the tenets of the Helsinki Declaration. All study 
participants received written information about the study and gave their written informed 
consent. 
3.4 SUBJECTS 
Studies I and II 
Patients with mild head injury and no trauma to other body parts, arriving at the ED no longer 
than 24 hours after the injury were recruited prospectively to the study from seven regional 
and county hospitals in Sweden from March 2008 until September 2009. 
One hundred and seventy-three patients aged 15-70 were recruited. One patient was 
diagnosed with a brain tumor later and was, therefore, excluded from the study. One patient 
was 76 years and was included due to a protocol violation. 
Inclusion criteria: closed head trauma with loss of consciousness of less than 30 minutes and 
/or post-traumatic amnesia (PTA) less than 1hour, GCS 14-15 at the arrival to the ED. 
Exclusion criteria were as follows: 1) need for neurosurgery or intensive care, 2) other 
significant physical injury requiring surgery; 3) any significant somatic or psychiatric disease 
of a severity likely to impact activities of everyday living; 4) a history of an mTBI that 
required medical attention during the last 5 years; 5) previous moderate or severe traumatic 
brain injury; and insufficient knowledge of the Swedish language. 
Studies III and IV 
Eligible were fifteen consecutive patients presenting to the ED of the Danderyd Hospital, 
Stockholm, Sweden due to mTBI of such extent that they required an acute CT-scan. 
All patients with mTBI met diagnostic criteria according to guidelines of the Mild Traumatic 
Brain Injury Committee of the American Congress of Rehabilitation Medicine (ACRM) (18) 
and according to the conceptual mTBI definition provided by WHO Collaborating Center of 
Neurotrauma Task Force on mTBI (17): mTBI is an acute brain injury resulting from 
mechanical energy to the head from external physical forces. Operational criteria for clinical 
identification include: (i) One or more of the following: confusion or disorientation, loss of 
consciousness (LOC) for 30 minutes or less, post-traumatic amnesia (PTA) for less than 24 
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hours, and/or other transient neurological abnormalities such as focal signs, seizure, and 
intracranial lesion not requiring surgery; (ii) Glasgow Coma Scale (GCS) (2) score of 13–15 
after 30 minutes post-injury or later upon presentation for healthcare. The manifestations of 
mTBI must not be due to alcohol, drugs, and medications, caused by other injuries or 
treatment for other injuries, caused by other problems (e.g. psychological trauma, a language 
barrier or coexisting medical conditions), or by penetrating craniocerebral injury. 
Patients were excluded if the duration of loss of consciousness was uncertain (e.g. in 
combination with alcohol intoxication), if they had contraindications to MRI, any head injury 
in the previous year requiring medical attention, progressive neurological disorder or any 
other injury/illness with a short expected survival, need for help in daily living before the 
current injury, severe visual impairment or manifest strabismus, or were non-Swedish 
speaking. 
Two control groups were included in the study. The first was an orthopedic control group 
consisting of 15 patients with minor trauma to hand, arm, foot or leg without need of surgical 
intervention. Inclusion of orthopedic controls was non-systematically intermittent during the 
same time period as the patients with mTBI. The second control group included staff from the 
Department of Rehabilitation Medicine, their friends and family members. All study 
participants were 18-40 years of age. 
3.5 NON-PARTICIPANTS 
Studies I and II 
Seventy-six eligible patients who received study information did not consent to participation 
in the study. These patients were younger than those who agreed to participate (mean age 
29.6 years vs. 39.4 years, p < 0.001) and more often men (66% vs. 45%, p = 0.003). 
Studies III and IV 
Ninety-nine patients declined participation in the study: 17 patients with mTBI and 82 
patients with minor orthopedic trauma. Most of those who declined were men (88% of 
patients with mTBI and 64% of orthopedic trauma patients). There was no statistically 
significant difference regarding age between participating and non-participating subjects. In 
most cases, the reasons for non-participation were a lack of time and engagement, 
inconvenience regarding the assessment time frame. 
3.6 STATISTICAL ANALYSIS 
Studies I and II 
All variables were analyzed with descriptive statistics such as mean, standard deviation, 95% 
Confidence Interval (CI) or median and interquartile range. 
Analysis of variance for repeated measures (ANOVA) was used to report mean RPQ scores, 
and efficacy was expressed as the interaction between the groups and time. Analysis of data 
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revealed positively skewed distributions of symptom intensity for each of the RPQ symptom 
ratings. A change score was calculated and then compared between the groups regarding 
amelioration rate. Non-parametric tests, such as, Kruskal-Wallis (three groups) and Mann-
Whitney U (two groups) were used to analyze efficacy, i.e. differences between the groups in 
change of separate symptom intensity from baseline to follow-up. 
Results of SF-36 were presented as median and IQR, since it is an ordinal scale; however, 
mean and 95% confidence intervals are often presented and are, therefore, also included. In 
order to explore associations with outcome, univariate binary logistic regression analysis was 
performed. 
Data were analyzed with SPSS version 20. The significance level was p < 0.05 (two-tailed) in 
all comparisons. 
Studies III and IV 
Oculomotor measures (accommodation, convergence, fusional vergence and saccades) were 
analyzed with parametric statistics. Interactions between the groups (between-subject factor) 
and within the group (within-subject factor, baseline to follow-up) were analyzed with two-
way analysis of variance for repeated measures. Post-hoc analysis with Holm-Bonferroni 
adjustment for multiple comparisons was performed. Fischer’s exact test was applied for 
analysis of the categorical data (study III). Dunnet’s post-hoc test was used to control for 
multiplicity (IV). Ordinal data from questionnaires were analyzed with non-parametric 
statistics: the Kruskal-Wallis test (three groups), Mann-Whitney U test (two groups, post-hoc 
analysis), Wilcoxon Signed-ranks test and Spearman’s rank correlation test. 
Data were analyzed using SPSS version 23. Two-tailed p values were used with a critical 
significance level of p < 0.05. 
3.7 OUTCOME MEASURES 
3.7.1 Evaluation of symptoms, activity and participation, and health related 
quality of life 
Rivermead Post Concussion Symptoms Questionnaire (RPQ) 
The RPQ is a self-rated Likert scale type questionnaire for measuring symptoms that are 
often reported after mTBI. This scale evaluates 16 symptoms: headaches, dizziness, 
nausea/vomiting, fatigue, noise sensitivity, light sensitivity, irritability, feeling depressed, 
sleep disturbance, feeling frustrated, restlessness, forgetfulness, poor concentration, taking 
longer to think, blurred vision, double vision. Patients are asked to rate symptoms compared 
to pre-injury status on a scale of 0-4, where 0 means “not a problem”, 1 – “no more of a 
problem”, 2 - “mild”, 3 – “moderate”, and 4 – “severe problems”. The mean score of the 16 
items/symptoms, i.e. symptom load was calculated as the primary outcome measure (study I). 
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RPQ has shown good test-retest reliability 7-10 days and 6 months after mTBI (141). Rasch 
analysis (a mathematical model, which determines whether items from the scale in the 
questionnaire fit into this model) of the RPQ (147) has shown that RPQ is not a 
unidimensional instrument. RPQ questions were separated into two symptom scales RPQ-13 
and RPQ-3, and each of these scales have shown unidimensionality. Structural analysis of the 
RPQ (148) showed that this questionnaire has a three factor, not a one factor structure, 
including somatic, cognitive and emotional factors, but that there is a high degree of co-
variation between factors. Putting somatic and emotional factors together into a two-factor 
model showed goodness–of–fit to the data. 
Hospital Anxiety and Depression Scale (HADS) 
The HADS is a short self-reported questionnaire, which is used to assess anxiety and 
depression levels (142). This questionnaire consists of the two subscales, the HADS –anxiety 
and HADS-depression scale with 7 items each. Patients are asked to rate their symptoms 
during the past week. Each item has a 4-point scale from 0 (not at all) to 3 (very often) with a 
maximum score of 21 for each of two scales. In each domain scores of 0-7 are categorized as 
normal, 11-14 – as moderate, and 15-21 as severe. 
HADS showed good sensitivity and specificity at a cut-off score over 8 for each of the two 
scales (149). 
Occupational Gaps Questionnaire (OGQ) 
The OGQ was developed so as to measure the individuals’ perceived participation in 
activities of everyday life, in social and work-related activities. The ability to perform 
everyday activities might be affected because of the disease or illness. Individuals might 
perceive difficulties in everyday occupations causing a gap between what the individual 
wants to do and what they actually do. Consequently, the gap might appear between what the 
individual does but does not want to do. The presence of occupational gaps in OGQ is 
examined in 28 activities, consisting of 8 instrumental activities of daily living, 6 social 
activities, 10 leisure activities and 4 work-related activities. This questionnaire has been 
validated in different medical conditions such as stroke, subarachnoid hemorrhage and 
traumatic brain injury inclusive mTBI (143). 
Rivermead Head Injury Follow Up Questionnaire (RHFUQ) 
The RHFUQ measures self-rated head injury-related changes in routine domestic activities 
and in participation in work and social life, and interactions with family and friends (144). 
This questionnaire was developed in order to assess activity and participation after mild to 
moderate brain injury. RHFUQ includes ten questions with ratings on a Likert scale from 0 to 
4: 0 – “no change”, 1 – “no change, but more difficult”, 2 – “mild change”, 3 – “moderate 
change”, 4 – “very marked change”. Ratings 2-4, “mild change” to “very marked change” 
were aggregated to a single score “Problems”. Summarizing scores for all ten items gives a 
total score with a maximum of 40. 
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According to previous studies (61, 77), we have dichotomized summary scoring of injury-
related every day activities on RHFUQ as follows: a total sum score less than 8 meaning a 
“good” outcome and a sum score of 8 or higher meaning an “unfavorable” outcome. 
Short-Form Health Questionnaire (SF-36) 
The SF-36 is a short form survey of health-related quality of life (145). It consists of 36 
questions and assess eight health scales/domains: 1) limitations in physical activities due to 
health problems; 2) limitations in social activities due to physical or emotional problems; 3) 
limitations in usual role activities due to physical health problems; 4) bodily pain; 5) general 
mental health (psychological distress and well-being); 6) limitations in usual role activities 
due to emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions. 
Patients are asked to rate their health over the past 4 weeks. One of the 36 questions asks 
about health over the past year and is not included in the eight health domains. The SF-36 
scales are summarized in two distinct summary scores: the Physical Component Summary 
(PCS) and Mental Component Summary (MCS). In order to evaluate the results of the SF-36, 
each scale is transformed into a 0-100 scale where a lower score means greater disability, and 
higher score means less disability. 
The SF-36 is a generic questionnaire. It targets general and specific populations, and is used 
to estimate the impact of different treatments on general health. In 1995, Sullivan et al. 
published an article exploring the reliability and construct validity of the Swedish version of 
the SF-36 in a large Swedish general population (146). In all, 8 930 respondents participated 
in seven general population surveys (age interval 15-93 years, mean age 42.6 years). The 
Swedish study showed a good internal validity and reliability across different age and socio-
demographic groups (146). 
3.7.2 Vision 
Visual examination 
Experienced licensed optometrists performed visual examinations of all study participants in 
agreement with a standard clinical optometric procedure. It included assessment of 
monocular and binocular visual acuity at far and at near, refractive error, near point of 
accommodation, accommodation facility, near point of convergence, fusional vergence and 
non-strabismic eye-turn, heterophoria. Visual dysfunctions were diagnosed according to 
established diagnostic criteria (150). One of the oculomotor –based visual impairments is 
convergence insufficiency (CI). The point, where eyes achieve maximum convergence, is 
called the near point of convergence (NPC). Convergence insufficiency was diagnosed when 
NPC was at a distance greater than 6 cm plus at least one of the following: reduced PFV at 
near (< 20 prism diopters) or divergent heterophoria at least four prism diopters greater at 
near than at distance (150). Positive fusional vergence is an ability to align the eyes despite 
the increasing vergence demands, as it is in assessment with a prism bar. The patient was 
instructed to try as hard as possible to maintain single vision while the examiner was 
gradually increasing the strength of the prism, and then to report when double vision 
 22 
appeared. A similar procedure was used in the testing of NPC, which was measured with an 
RAF-ruler. Expected accommodative amplitude was calculated according to the Hofstetter 
formula (18.5-1/3 age). Accommodative insufficiency was diagnosed if the accommodative 
amplitude was below the minimum expected according to the Hofstetter formula (15-1/4 age) 
(150). 
Saccades 
Saccadic eye movements were recorded (spatial res 0.15 degrees; temporal res 300 Hz) using 
an eye tracker (Tobii TX300, Tobii Corp., Stockholm, Sweden, www.tobii.com). The 
participant was seated so that his head was positioned at a distance of 60 cm in front of the 
eye tracker stimulus screen. Three saccadic test paradigms were used: (1) stimuli-induced 
pro-saccades; 2) anti-saccades; and (3) self-paced saccades. The stimuli consisted of a dot 
with a diameter of 5 mm (0.5 degrees). In the prosaccade paradigm the participant fixated on 
a centered cross and then re-fixated to a dot that appeared at 2, 4, 6, or 8 degrees to the left or 
right of the cross. The performance was characterized with mean latency and positional gain. 
In the anti-saccade paradigm, the participant viewed a centered cross and was instructed to 
inhibit their reflexive gaze at a dot presented 8 degrees to the left or right of the center, and, 
instead, rapidly look in the opposite, mirror-wise location of the presenting dot. Antisaccades 
were characterized with the latency of correctly performed saccades and proportion of 
erroneous saccades. In the self-paced saccade paradigm, two dots were simultaneously 
presented for 30 seconds at 8 degrees to the left and right of center. The participant was 
instructed to move the gaze rapidly, as many times as possible, between the dots. The 
performance was characterized with the number of saccades performed in 30 seconds and the 
mean intersaccadic interval. 
Visual symptoms 
Visual symptoms were assessed at the baseline and at follow-up using the Convergence 
Insufficiency Symptom Survey (CISS) (151, 152). The CISS assesses near work-related 
visual symptoms (151) and includes assessment of direct symptoms, such as blurred vision 
and double vision, as well as indirect symptoms (difficulty maintaining concentration, 
sleepiness while reading, headache and ocular discomfort). The survey includes 15 questions 
with ratings from 0 ‘never’ to 4 ‘always’ for assessment of visual symptoms. The total score 
is 60 and the cut-off score for abnormal levels of symptoms is 21. This value gives good 
sensitivity (97.8%) and specificity (87%) in otherwise healthy young adults who have 
presented to optometrists with visual symptoms (152). 
3.7.3 Fatigue and cognition 
Fatigue Severity Scale (FSS) 
General, or trait fatigue, was measured with FSS (98). The FSS is a questionnaire, which 
includes 9 questions on a 7-point Likert scale: from 1 - “Strongly disagree” to 7  - “Strongly 
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agree”. The final score is an average of all 9 questions scores. A higher score means a higher 
level of fatigue. The cut-off score of 4 and above indicates perceived present fatigue. 
Cognitive tests 
All patients were assessed with four neuropsychological tests: The Digit Symbol Substitution 
Test (153), The WAIS-III Digit Span test, The Ruff 2 & 7 Selective Attention Test (154), The 
Swedish Lexical Decision Test. 
The Digit Symbol Substitution Test (DSST) (153) is a well-established psychometric test 
paradigm used for measuring psychomotor processing speed. Participants were asked to write 
down one of the 9 corresponding symbols paired to a digit, as quickly as possible. This test 
requires a continuous performance during 120 seconds. The test score is a number of correct 
matches between digits and symbols. Before starting this test, participants were allowed to 
perform one session with 7 digits to practice, according to the test manual. Learning capacity 
can influence psychomotor speed; therefore, the participants were asked to write down the 
correct symbol under each digit twice after four completed rows, hence measuring incidental 
memory, i.e. memory for information which was secondary to the task and which participants 
were not instructed to remember (155). 
Cognitive fatigability (DSST-f) was calculated in this study by subtracting the score for the 
first half of the test (60 first seconds) from that from the last part of the test (60 last seconds), 
where the negative score indicated reduced performance on the test. Generally, it is expected 
that due to learning, the number of digits would increase in the second part of the test. 
Therefore, a non-increasing test score could indicate fatigability (155). 
The WAIS-III Digit Span test (DS) was used to measure verbal attention span with a forward 
repetition of digits, and verbal working, or short-term, memory with backward repetition of 
digits, that requires executive function (153, 156). Sum scores for forward and backward 
repetition are presented separately. 
The Ruff 2 & 7 Selective Attention Test (154) measures visual automatic detection speed 
(ADS) and automatic detection accuracy (ADA), controlled search speed (CSS) and 
controlled search accuracy (CSA). The participants had to mark targets, numbered 2 and 7, 
that were embedded among the letters (ADS) or among the other numbers (CSS). The test 
consists of a randomly ordered 10 sections measuring ADS and 10 sections measuring CSS. 
The test, with total time of 5 minutes, was administered as a continuous performance test 
according to the manual (154). Correct markings of targets and errors were counted after each 
section. Accuracy scores were calculated as the number of targets identified in relation to all 
possible targets. Higher scores indicated better performance. One section of ADS and one 
section of CSS were allowed for practice before the test. 
The Swedish Lexical Decision Test (SLDT) test measures the estimated premorbid cognitive 
global function (premorbid intelligence) based on word knowledge (157). Participants were 
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presented with a list of words, and they had to decide whether the word was a real or 
fictional. 
3.7.4 Sickness absence 
Sickness absence is an absence from the work that is attributed to sickness by the employee 
himself or by their physician. Sickness absence includes sickness benefits such as sick leave 
and disability pension that can be for full-time or part-time. People on part-time sick leave or 
disability pension can work part time. 
Register data from the Swedish Social Insurance Agency were collected on all study patients 
regarding compensated sick leave days for the time period 6 months before the mTBI and 12 
months after the injury. Data on disability pensions were also included if applicable. Data on 
one of the patients were not included due to an administrative error. 
Register data from the Social Insurance Agency in Sweden include sick leave diagnoses 
codes according to International Classification of Diseases, 10th Revision (ICD-10) (47). The 
codes are presented at a three-digits level. However, the closest code to diagnosis of mTBI in 
ICD-10 is S06.0 “Concussion” or “Commotio cerebri” that includes four digits and is, 
therefore, not available in the Social Insurance Agency register. In this study, in order to 
define sickness absence due to mTBI, the code S06 “Intracranial injury” was used. Data on 
two study patients with diagnosis codes describing medical conditions similar to that of S06.0 
were included; one patient had a diagnosis F072 “Postconcussional syndrome”, another 
patient had the diagnosis S099 “Other and unspecified head injuries”. 
 
4 RESULTS 
4.1 STUDIES I AND II 
A flow-chart of the study is shown in Figure 1. 
In both randomized groups, 83% of study patients completed the study. There were 
statistically significantly more falls as the injury mechanism in EIV group compare to TAU 
group (χ2 = 6.27, p = 0.012). No other differences between randomized groups were found 
regarding sociodemographic or clinical characteristics. 
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Figure 1. Flow-chart of the studies I and II. 
The CT-scan of the brain showed the following results: in the EIV group one patient had both 
a skull fracture and small hemorrhage, and one patient had a skull fracture; in the TAU group, 
one patient had a small hemorrhage and three patients had skull fractures; in the non-
randomized group, 2 patients had small hemorrhages and 3 patients had skull fractures. 
Sociodemographic characteristics of study patients are presented in Table 1. 
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Table 1. Sociodemographic and clinical characteristics of patients randomized to treatment as 
usual (n = 49) or to an early intervention (n = 48), and non-randomized patients (n = 76). 
 
 
4.1.1 Symptoms reporting on RPQ in high and low risk groups 
No statistically significant difference regarding the symptoms between the two high risk 
groups, EIV and TAU were found at follow-up [t(78) = 1.62, p = 0.11]. Symptom load was 
statistically significantly higher in the EIV group compared to the TAU group at the baseline 
[t(95) = 2.24, p = 0.027]. Symptom load decreased statistically significantly in both 
randomized groups [F(1, 78) = 58.28, p < 0.001], but no statistically significant difference 
was found between the two randomized groups in the amelioration rate [F(1, 78) < 1.00, p = 
0.790] from baseline to follow-up. 
The intensity of each of the RPQ symptoms was analyzed at group level as is shown in 
Figure 2. The symptoms “Headache” and “Fatigue” had the highest intensity at the baseline 
in both randomized groups, and in the TAU group at follow-up. In the EIV group most 
prominent symptoms at follow-up were “Fatigue” and “Poor concentration”. 
In the non-randomized group symptom load was lower compared to the randomized groups, 
and there was no statistically significant difference in the change of each of the symptoms 
over time. 
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Figure 2. Mean symptom intensity scores at baseline and at 3 months post-injury in (a) 
patients randomized to early intervention, (b) patients randomized to treatment-as-usual and 
(c) non-randomized, low risk patients. 
Anxiety and depression 
Three patients in the EIV group had treatment for anxiety and depression disorders with 
psychotherapy or serotonin reuptake inhibitors prior to mTBI, as revealed at the intervention 
visit. One patient, who was diagnosed with depression symptoms by clinical examination and 
HADS scores during the intervention visit, declined the recommended anti-depressive 
treatment. These four patients’ psychiatric morbidity did not affect their everyday life 
activities before the injury, and they were included in the study.’ 
4.1.2 Outcome regarding activity and participation 
RHFUQ 
Analysis of the activity and participation items in RHFUQ showed that a large proportion of 
the patients in non-randomized group reported having no change in most of the items 
compared to before the injury. Statistically significant difference was found regarding 
reported changes in everyday and social activities in RHFUQ between two randomized and 
non-randomized groups (df = 2, p < 0.001)(Kruskal-Wallis test). Post-hoc analysis with the 
Mann-Whitney U test showed a significant difference between the EIV group and non-
randomized group (U = 705.0, p < 0.001), and between the TAU and non-randomized group 
(U = 730.5, p < 0.001) (Mann-Whitney U test). No statistically significant difference was 
found between the two randomized groups. Patients in all three groups reported the highest 
rating in the item “Work more tiring”. 
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OGQ 
A statistically significant difference between the randomized and non-randomized groups was 
found (df = 2, p < 0.001) (Kruskal-Wallis test) regarding the reported occupational gaps in 
the OGQ questionnaire at the baseline on day 10 after the injury (Figure 3). Each randomized 
group differed statistically significantly compared to the non-randomized group: EIV versus 
non-randomized group (U = 379.5, p < 0.001), and TAU versus non-randomized group (U = 
341.5, p < 0.001). There was no significant difference at the baseline between randomized 
groups regarding occupational gaps (U = 581.5, p = 0.88) (Mann-Whitney U test). No 
difference regarding occupational gaps was found between any of the groups at the follow-
up. The number of occupational gaps decreased in all three groups from baseline to follow-up 
(Figure 3). A statistically significant decline in occupational gaps was found between baseline 
and follow-up in the EIV group (z = -1.117, p < 0.001) and in the TAU group (z = -4.26, p = 
<0.001) (Wilcoxon Signed-ranks test) with no significant difference in non-randomized 
group. The non-randomized group had a low number of occupational gaps in all items at both 
time-points. There was a statistically significant difference in change over time in all three 
groups regarding reported occupational gaps (df = 2, p < 0.001) (Kruskal-Wallis test) with a 
significant difference between the EIV and non-randomized group (U = 627.0, p < 0.001) and 
between the TAU and non-randomized group (U = 608.0, p < 0.001) with no difference 
between the two randomized groups (U = 747.5, p < 0.9) (Mann-Whitney U test). 
 
Figure 3. Sum of perceived occupational gaps at 10 days, baseline and at 3 months, follow-up 
after mTBI in early intervention (EIV), treatment-as usual (TAU) and non-randomized 
groups. 
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In both randomized groups, EIV and TAU, the predominant occupational gap “not doing but 
wanting to do” was reported in social and leisure activities, such as sports, seeing relatives 
and friends, engaging in societies, clubs and unions. Another type of occupational gap “doing 
but not wanting to do” was most prevalent in all three groups regarding activities of 
instrumental ADL such as shopping, cooking, washing clothes, cleaning, performing light 
maintenance, and managing personal finances both at baseline and at follow-up. 
4.1.3 Outcome regarding quality of life 
SF-36 
Both randomized groups reported a lower quality of life compared to the non-randomized 
group. There was a significant difference among the three groups regarding SF-36 data in the 
scales Vitality (df =2, p = 0.01), Mental Health (df = 2, p = 0.001), Bodily Pain (df =2, p = 
0.04), (Kruskal-Wallis test). Post-hoc analysis with the Mann-Whitney U test revealed a 
statistically significant difference between the EIV and non-randomized groups in Vitality (U 
= 685.5, p < 0.001), Mental Health (U = 808.0, p = 0.005), Bodily Pain (U = 887.0, p = 
0.017), Role Physical (U = 973.5, p = 0.038), and between the TAU and non-randomized 
groups in Vitality (U = 759.0, p = 0.023), General Health (U = 767.5, p = 0.027), Role 
Emotional (U = 905.5, p = 0.024). Regarding Mental Component Score (MCS) in SF-36, a 
statistically significant difference was observed between all three groups (df = 2, p = 0.011) 
(Kruskal-Wallis test), and between the EIV and non-randomized groups (U = 784.0, p = 
0.007), and the TAU and non-randomized groups (U = 730, p = 0.028) (Mann-Whitney U 
test) (Figure 4). No difference was found between the two randomized groups. 
 
Figure 4. Short-Form 36 (SF-36) summary measures: physical component score and mental 
component score. TAU: treatment as usual; EIV: early intervention. ° mild outliers, * extreme 
outliers. 
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4.1.4 Outcome regarding sickness absence 
The majority of the eligible patients (76%, 131 of 172) had no sickness absence 
compensation between 6 months before and 12 months after mTBI. Totally, thirty patients 
had sick leave after mTBI. There were 8 patients in EIV group and 6 patients in TAU group 
who had sick leave due to diagnosis S06 ”Intracranial injury” (Figure 5). Most of the patients 
with sickness absence after mTBI discontinued their sick leave in less than 3 months. 
 
Figure 5. Distribution of the number of sick leave days in the 14 patients with the diagnosis 
“Intracranial injury”, S06. The number of sick leave days is presented as “gross” days, i.e. 
regardless of whether sick leave applies only to part of the day. 
 
Figure 6. Distribution and duration of all sick leave periods (during the period 6 months 
before to 12 months after MTBI) among the patients in all three groups. 
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Eleven patients that were on disability pension during the period 6 months before and 12 
months after mTBI had been on disability pension to the same extent both before and after 
the injury. Four of them had part-time sick leave and disability pension (158). During the 
period of 6 months before mTBI only 9 patients (5%) had sick leave (longer than 14 days). 
Few patients, mostly in the EIV group, had longer sick leave periods after mTBI. Patients that 
had longer periods of sick leave after mTBI did not tend to have more sickness absence 
before the injury (Figure 6). In the EIV group, one patient had sick leave after mTBI with 
diagnosis code S06 and then again, after returning to previous activities, had sick leave period 
with the diagnosis of depression. 
4.2 STUDIES III AND IV 
Patients were assessed twice after mTBI in studies III and IV, at baseline, also called as sub-
acute stage, and at follow-up. CT-scan of the brain showed that two of the patients with 
mTBI had pathological changes without the need for neurosurgery: one had a small subdural 
hemorrhage and the other a small subarachnoid hemorrhage. Sociodemographic 
characteristics are shown in Table 2. 
Table 2. Sociodemographic characteristics of patients with mTBI, orthopedic and non-injured 
controls. 
 
4.2.1 Vision 
Visual assessments 
Accommodation 
Regarding the deviation from expected accommodative amplitude, a significant effect of 
interaction between groups and test occasions was found in the ANOVA (df=2, F=4.406, p = 
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0.028). At the baseline, statistically significantly reduced accommodative amplitude (p = 
0.001) was found in the mTBI group compared to a non-injured control group, and no 
significant difference between the mTBI and orthopedic control groups according to post-hoc 
analysis (Figure 7). No difference was found between all three groups at follow-up. Of all 15 
patients with mTBI, 12 had accommodative insufficiency (AI) at the baseline, and 6 out of 13 
patients with mTBI still had AI at follow-up compared to 5 out of 12 orthopedic controls and 
2 out of 15 non-injured controls, with no changes over time in both control groups. There was 
no statistically significant difference in accommodative facility within or between the groups 
or test occasions. 
Figure 7. Deviation from expected accommodative amplitude. The lower the negative value, 
the greater the deviation (insufficiency). Closer to zero is better. The miniature squares 
indicate mean values. The box indicates median, upper and lower quartiles. The whiskers 
indicate minimum and maximum. * Significant difference (p = 0.015). 
Convergence 
There were no significant differences between the mTBI group and both control groups at 
either occasion. There was a statistical significant improvement in the mTBI group, as shown 
with post-hoc analysis, from baseline to follow-up (p = 0.015) (Figure 8). No statistically 
significant differences were found between or within both control groups. 
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Figure 8. Near point of convergence in the mild traumatic brain injury (mTBI) group at 
baseline and at follow-up measured in centimeter. The lower the value, the better the 
convergence performance. The miniature squares indicate mean values. The box indicates 
median, upper and lower quartile. The whiskers indicate minimum and maximum.                  
* Significant difference (p = 0.015). 
Fusional vergence 
The ANOVA on fusional vergence did not show any significant differences at the group level 
at any time point. 
Saccade performance 
No statistically significant difference in latency was found between groups or test occasions 
in the prosaccade task (ANOVA). There were no significant differences within or between 
groups in the self-paced saccade task. Performance of the antisaccade task in all three groups 
showed no statistically significant differences in latency or proportion of erroneous saccades. 
Assessment of visual symptoms 
 A statistically significant difference in CISS score between the three groups was found at the 
baseline (df = 2, p = 0.003) (Kruskal-Wallis test). Post-hoc analysis revealed that patients 
with mTBI had more visual symptoms with near work at the baseline compared to both 
control groups: patients with mTBI versus orthopedic controls (U = 47.5, p = 0.012) and 
patients with mTBI versus non-injured controls (U = 38.0, p = 0.02) (Mann-Whitney U test). 
In the mTBI group, the median value of the CISS score decreased from 24 at the baseline to 
19 at follow-up without reaching statistical significance (Wilcoxon Signed-ranks test). In the 
control groups the CISS score was bellow cut-off level at both time points. 
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Figure 9 illustrates associations between CISS score and AI/CI in all three groups at both 
time points. According to CISS, nine of twelve patients with mTBI were identified with CI or 
AI at baseline, and seven patients with mTBI still had CI or AI at follow-up: one with CI and 
six with AI. Three of these patients score above the cut-off level on CISS. There was no 
association found between CISS and CI/AI (Fischer’s exact test). 
 
Figure 9. The association between Convergence Insufficiency Symptom Survey (CISS) score 
and the presence of accommodative insufficiency (AI) or convergence insufficiency (CI) in 
patients with mild traumatic brain injury (mTBI), orthopedic controls and non-injured 
controls. The findings at baseline and at follow-up are presented in a two-by-two matrix. 
The CISS scores correlated at baseline with reduced PFV measured at near, i.e., the capacity 
to maintain clear single vision while performing near work. (r = -0.6, p = 0.02) (Figure 10). 
 
Figure 10. Convergence Insufficiency Symptom Survey (CISS) score versus positive fusional 
vergence in patients with mild traumatic brain injury (mTBI). Higher positive fusion value 
corresponds to better function. 
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Symptoms measured by the RPQ 
A statistically significant difference was found among the three groups in the sum of 
symptoms scores on RPQ at baseline (df = 2, p < 0.01) and at follow-up (df = 2, p = 0.001) 
(Kruskal-Wallis test). Post-hoc analysis showed a statistically significant difference in the 
RPQ sum of symptom scores between the mTBI group and the orthopedic control group (U = 
40.0, p = 0.002) and between the mTBI group and the non-injured control group (U= 40.0, p 
= 0.002) at baseline, as well as at follow-up: mTBI versus the orthopedic group (U = 27.0, p 
= 0.003), mTBI versus the non-injured control group (U = 24.0, p < 0.001) (Mann-Whitney U 
test). The sum of symptom scores decreased in the mTBI group over time, but the difference 
did not reach statistical significance (p = 0.092) (Wilcoxon Signed-ranks test). 
4.2.2 Fatigue and cognition 
The first neuropsychological examination at the sub-acute stage was performed in the mTBI 
group the median was 6 days after the injury (range 4-12 days) and for the orthopedic 
controls 8 days (range 2-9 days). The median time for the follow-up neuropsychological 
examination was 95 days (range 81-225 days) for the patients with mTBI and 108 days 
(range 87-324 days) for the orthopedic controls. There were no differences in age, gender, 
length of education or estimated IQ between the two trauma groups, but the non-injured 
control group had a significantly longer education and a higher estimated full-scale IQ. 
Sub-acute stage  
There was a statistically significant difference between the three groups for self-rated 
acquired fatigue, RPQ-f (df = 2, p = .001), and the mTBI group scored significantly higher on 
acquired fatigue compared to the orthopedic control group (U = 58.5, p = .023) (Fig.11a). The 
patients with mTBI scored around the cut-off level for trait fatigue (FSS) (Fig.11b). There 
was also a statistically significant difference regarding trait fatigue (FSS) between the three 
groups (df = 2, p = .033), but trait fatigue did not differ significantly between the mTBI group 
and the orthopedic control group (U = 64.5, p = .077) (table 3). When comparing three groups 
regarding cognitive fatigability (DSST-f), no statistically significant difference was found 
(F(2,41) = 2.964, p = .063). The post-hoc analysis with the Dunnett test showed that the 
patients with mTBI had more fatigability compared to the orthopedic controls, mean 
difference, (2.80, [0.12 – 5.48], p = .039) (Fig. 11c). 
 
Figure 11 a-c. Acquired fatigue, trait fatigue and cognitive fatigability at sub-acute stage and 
at follow-up. * p < .05 
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There was no difference between the three groups regarding anxiety and depression at the 
sub-acute stage. In the mTBI group, anxiety correlated with trait fatigue (FSS) (rmTBI = .716, 
p = .006). Depression did not correlate with any of the fatigue measurements. 
Visual functions such as convergence, accommodation did not correlate to any of the fatigue 
measures. Regarding saccade measurements, there were no statistically significant differences 
between the three groups, except for the variability of prosaccade latency (PSL) (F(2,39) = 
3.543, p = .039). Post-hoc analysis with the Dunnet test showed a statistically significant 
larger variability of prosaccade latency between the mTBI group and the orthopedic control 
group, mean difference, (-14.55, [-28.62 – -.47], p = .042), but not between the mTBI group 
and the non-injured control group.  In the mTBI group, some of the saccade measures 
correlated to different fatigue measures. Acquired fatigue (RPQ-f) correlated positively with 
PSL (rmTBI = .690, p = .006), but not with any of the other saccade measures. That is, the 
higher the acquired fatigue, the higher the prosaccade latency. 
Trait fatigue (FSS) correlated with antisaccade latency (ASL) (rmTBI = .588, p = .035) and 
also with the variability of ASL (rmTBI = .637, p = .019). That is, the higher the scores of trait 
fatigue the higher the latency and higher variability in antisaccade presentation. However, 
there was a high correlation between FSS and anxiety among the patients with mTBI. When 
partial correlation was performed, the correlation between FSS and antisaccade latency, 
controlling for anxiety, did not remain significant for any of the groups. 
In the mTBI group, acquired fatigue correlated with cognitive fatigability (DSST-f) (rmTBI = -
.527, p = .043). That is, the higher the self-rated fatigue the greater the fatigability. Trait 
fatigue did not correlate with any of the attention measurements in the mTBI group.  For the 
mTBI group, cognitive fatigability (DSST-f) correlated positively with controlled search 
accuracy (CSA) (rmTBI = .585, p = .022). That is, the more fatigability, the more errors on 
Ruff 2&7 on the subtask demanding controlled attention functions. No correlations were 
found between cognitive fatigability and incidental memory, attention span or working 
memory in any of the groups. 
Follow-up 
Both acquired fatigue and cognitive fatigability improved from the sub-acute stage for the 
patients with mTBI to the follow-up. There were no longer significant differences between 
the mTBI and control groups regarding acquired fatigue, trait fatigue (FSS) or cognitive 
fatigability. None of the patients with mTBI had severe problems with fatigue at follow-up. 
However, nearly half of the patients with mTBI had some residual problems with acquired 
fatigue. Most of the patients with mTBI improved from the sub-acute stage regarding 
cognitive fatigability. However, three of the patients showed poorer results compared to the 
sub-acute stage. 
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5 DISCUSSION 
5.1 INTERVENTION FOR PATIENTS AT RISK FOR PERSISTING DISABILITY 
The intervention in this study aimed to promote a good outcome in patients who were 
considered at high risk for prolonged symptoms. However, there was no effect of the 
intervention on reported symptoms, or on activity and participation three months after the 
injury. 
Previous studies provide sufficient evidence that early information on the usual course and a 
probable good prognosis is beneficial (14, 129, 159, 160). The written information given to 
all study patients might be sufficient to promote recovery, without an additive effect of the 
intervention. Furthermore, we also speculated that assessing and discussing possible 
comorbidities as a part of the intervention might, instead of reassuring patients of a possible 
good outcome, have alerted them to possible symptoms. Patients in the intervention group 
reported more symptoms and had more limitations in activity and participation at follow-up, 
but this was not a statistically significant. 
Another reason that we found no effect of the intervention might have been that criteria for 
identification of patients at risk for persisting problems were too narrow, for example, they 
only took into account the number of symptoms, not symptom severity. In this study, the 
group of patients with an estimated high risk for a poor outcome was defined by those who 
reported 3 or more symptoms, as it is described in the definition of Postconcussional 
syndrome in ICD-10 (47), a risk criterion also used in other studies (7). However, even when 
analyses were performed with other criteria, (more symptoms, greater severity of symptoms) 
we could not find any effect of the intervention (post-hoc analysis, unpublished data). 
The assessment that was a part of the intervention intended to capture treatable comorbidities 
such as anxiety, depression, pain and sleep disturbances. However, only a few patients 
actually had such comorbidities to a degree requiring treatment. Anxiety and depression are 
considered to be two important modifiable factors often found to affect the persistence of 
symptoms after mTBI (56, 161), but were, in fact, rare in the study group. Similarly, neither 
pain nor sleep problems were expressed at the intervention visit to the extent that they 
required treatment. This suggests that there might be other modifiable factors of interest to 
assess after mTBI.  
One such modifiable factor could be visual changes after mTBI. Another possible modifiable 
factor could be fatigue, which was the most severe symptom in both randomized groups in 
our study, and which is often reported in other studies (7, 8, 58). Fatigue was not addressed in 
the present intervention. However, capturing different aspects of fatigue might have given a 
better basis for planning additional interventions, and in that way affecting outcome for the 
patients in the intervention group. 
Reporting of symptoms after mTBI has also been suggested to be affected by pre-traumatic 
factors, including personal and social factors, and, therefore, a broader biopsychosocial 
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approach might have been more successful. Furthermore, the growing evidence shows that 
post-concussion symptoms are best described as an interaction between biological, 
psychological and social factors (57, 115, 162); and that not a single factor model, but a 
multidimensional approach, might be one way of finding predicting and modifiable factors 
(163). 
One of the strengths of this study was the use of the ICF framework for the evaluation of 
outcome, including ICF components such as reported function (symptoms), activity and 
participation, thus making it possible to evaluate a component of rehabilitation medicine in 
Sweden; that is, to help the injured person to be able to be active and participate in the society 
despite having symptoms. 
We have reported outcome regarding symptoms and disability at 3 months after mTBI. 
Therefore, conclusions cannot be drawn regarding the long-term effects of this early 
intervention, we can only speculate about the outcomes beyond the 3 months follow-up. 
Patients with complaints after mTBI present to health care providers at different times after 
the injury: early, at acute or sub-acute stage or later, sometimes after many months. Clinicians 
have to rule out alternative medical conditions and explanations that may account for 
continuing problems after mTBI, especially in the chronic stages; there is a risk that 
symptoms may be erroneously attributed to mTBI, and other treatable pathologies may be 
overlooked. 
5.2 STRATIFICATION OF PATIENTS BY SYMPTOMS EARLY AFTER mTBI 
Despite many years of research on mTBI, there are to date no commonly acceptable 
prognostic models that can identify patients who have a high risk for poor outcome, in the 
form of persisting symptoms and disability. Identifying high-risk group among patients with 
mTBI early after the injury is of a considerable importance for planning of adequate clinical 
management. 
Previous studies have shown that reporting many symptoms early after mTBI is associated 
with more reported symptoms 3 months after injury (7, 52, 164, 165) and with a poor 
outcome (7, 58). Based on previous research, a cut-off of 3 or more symptoms at ten days 
after the injury was used in our study as a discriminating criterion for identifying patients at 
high risk for persisting problems after mTBI. This stratification in to groups with high or low 
risk for poor outcome was shown to have some prognostic value. Patients who reported few 
symptoms at an early stage after mTBI continued to report few symptoms. Furthermore, 
patients in the group with an estimated low risk for a bad outcome, the non-randomized group 
in our study, also showed only minor limitations in activity and participation, and rated their 
health-related quality of life as good. This gives some support for the hypothesis that 
reporting few symptoms early after mTBI is a good prognostic factor. These findings were in 
line with Stulemeijer et al. study of early prediction of favorable outcome (166). 
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Symptoms after mTBI are the primary reason why patients seek health care. However, even 
though self-reported complaints are important and have been shown to have a predictive 
value (at least for patients with few symptoms predicting a good outcome), assessment 
limited to delineating symptoms might be not sufficient to identify patients at need of 
intervention or follow-up. Possibly, a combination of reported symptoms and objective 
findings might serve as a basis for prediction of outcome and a plan for intervention. For 
example, pre-injury psychiatric history, peri-injury stress, personal factors and early objective 
measures of brain dysfunction might all contribute to a future prognostic model. The concept 
of early prediction of outcome, both poor and good, is continuously investigated in studies of 
mTBI (11, 164, 166-168). Predictors of incomplete recovery after mTBI, shown in several 
studies (11, 163, 167), could be considered as modifiable factors for the intervention. Ideally, 
the prognostic targets should be identified early after mTBI, in ED or in close proximity to 
discharge. 
5.3 VISUAL CHANGES AFTER mTBI 
Results of our study indicate that there are differences in visual measures between mTBI 
group and both control groups early after the injury. The mTBI group differed statistically 
significantly from non-injured control group regarding accommodation amplitude at a sub-
acute stage after the injury. We found improvement of accommodation amplitude over time. 
However, there were more than half of the patients with mTBI who still had deviations in 
accommodation, meeting the criteria of accommodation insufficiency (AI) at follow-up, 
giving some support for accommodation as a potentially sensitive parameter for monitoring 
recovery after mTBI. This finding is in agreement with other studies (72, 78, 79, 81). 
Our study did not confirm findings in other studies that reported receded near point of 
convergence in patients with visual complaints after mTBI (72, 78, 169). One explanation for 
no difference in NPC between mTBI and both control groups might be that patients have 
recovered spontaneously during the time period after the injury before the baseline NPC 
measurements. Another explanation might be that patients with mTBI were using more effort 
to achieve normal performance on NPC. However, more effort applied might indicate more 
reported symptoms on the CISS. This idea is supported by our observation that increased 
symptoms on CISS correlated with reduced fusion, the most important component in the 
convergence eye movement. At follow-up, there was a statistically significant improvement 
over time in NPC in the mTBI group, and symptoms reported in CISS also improved in the 
mTBI group at follow-up. 
We did not find differences between the mTBI and control groups in most of the measures of 
the saccades in our study. It might be that saccadic eye movements were assessed too late, in 
the mTBI group, and the changes had already been normalized before the assessment at the 
sub-acute stage, in line with the results reported by Pearson et al. (84). In that study, boxers 
showed increased saccadic latency directly after a blow to the head during the fight, but after 
12 days, saccadic latency returned to the pre-fight level. 
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It might be speculated that increased effort to perform as well as practically possible on 
saccadic tests is expressed in reporting more symptoms, and this might indicate that more 
brain regions are involved. This hypothesis of a relationship between abnormal eye 
movements and changes in functional neural networks after mTBI was supported in a study 
by Johnson et al. (69) In this study, individuals with sports-related concussion were assessed 
with fMRI and simultaneously induced saccadic tasks at 7 days after the injury. Concussed 
persons showed a significantly worse performance on saccadic tests, at the same time, fMRI 
showed involvement of more brain regions compared to healthy controls (69). Despite an 
improvement in saccadic tests performance, and some improvement on fMRI, concussed 
persons showed altered brain activation patterns on fMRI at 30 days after the injury (170). 
Despite growing evidence that the oculomotor changes occur in patients with mTBI, there is 
a substantial heterogeneity in the design of studies assessing those changes, making it 
difficult to replicate the results (67). Study populations are usually small and have an 
inadequate description of the mTBI population and controls. There is no unified reporting of 
outcome measures; furthermore, different studies have different examining protocols and 
procedures with varying post-injury and follow-up periods (67). 
5.4 FATIGUE AND COGNITIVE FATIGABILITY AFTER mTBI AND 
ASSOCIATIONS WITH VISUAL CHANGES 
Fatigue is one of most common symptoms after mTBI (7, 8, 58). Assessment of fatigue is 
mostly based on self-reporting questionnaires, and as such is subjective. It could be 
speculated that assessing different aspects of fatigue, including the use of objective measures, 
could increase the possibility of individualizing treatment. 
One of our main findings regarding fatigue was that patients with mTBI had significantly 
more objectively measurable cognitive fatigability and self-reported acquired fatigue at the 
sub-acute stage compared to trauma controls with non-head injury. One can speculate that 
these findings might be attributed to brain injury. However, those changes were transient; 
there was a statistically significant improvement in cognitive fatigability in the mTBI group 
at follow-up, and there were no longer differences regarding self-rated fatigue measures 
between the patients with mTBI and the orthopedic controls at follow-up. 
Another important finding in patients with mTBI was a significant association between self-
rated acquired fatigue and objectively measurable cognitive fatigability. 
In patients with mTBI, associations were found during the sub-acute stage between acquired 
fatigue and prosaccade latency as well as between trait fatigue and antisaccades. The 
interpretation of these observations is difficult and need to be studied further. Generation of 
saccades involves several neural networks (68) that might be further affected in the already 
challenged brain after mTBI. It could be hypothesized that even subtle transient changes in 
visual networks could increase perceived fatigue. 
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6 LIMITATIONS 
Recruitment of patients with mTBI to research studies is known to be difficult and subject to 
several pitfalls. This was also the case in the present studies. One of the problems 
encountered during recruitment of patients is recruitment bias; that is, the recruited patients 
are not representative of the patients with mTBI presenting in clinical settings, making it 
difficult to generalize the results. This problem becomes more obvious in studies in which 
narrow inclusion criteria are applied to potential study participants. Hence, persons with pre-
injury comorbidities, such as psychiatric diseases or alcohol abuse, were excluded in our 
study. On the other hand, broad inclusion criteria would have made it difficult to interpret 
whether the symptoms the patient reports are due to the mTBI or due to the comorbidity. 
Furthermore, patients who declined participation in studies I and II were younger and mostly 
men, affecting the generalizability of the results. Similarly, there was a majority of men with 
mTBI that declined participation in studies III and IV. 
Furthermore, the mTBI sample in studies III and IV was small, leading to the increased risk 
of type II error, namely, a risk of not finding a true difference between the groups. In order to 
minimize effect of presbyopia, age of study participants in studies III and IV was restricted to 
18-40 years. Therefore, the findings of these studies can be attributed only to a population of 
young adults suffering mTBI, limiting generalizability. 
 
7 FUTURE STUDIES AND CLINICAL IMPLICATIONS 
There is still a need for continuous development of prediction models useful in different 
settings, at the ED, by general practitioner and at the rehab-center. Therefore, future studies 
could focus on prediction models. It is suggested that a standardized unit of measures could 
be employed, based on known predictive factors is suggested, similarly to the existing model 
for TBI prognosis (117). 
Further investigations are also needed in order to identify new modifiable factors and 
evaluate the effects of targeting these in interventions. 
There is a lack of evidence on which to base the management of impaired visual functions 
after mTBI. However, considering theoretical models and existing smaller studies, albeit with 
a risk of bias, it might be reasonable to refer patients with visual complaints to a vision care 
specialist as a part of general management of mTBI. Further investigation of the role of fMRI 
after mTBI could increase understanding of the pathophysiology behind symptoms and the 
recovery process. Changes in functional connectivity and the resting state mode might better 
define affected networks after trauma related to visual changes and fatigue. 
The findings in our study lend some support to the hypothesis that routine follow-up in all 
patients after mTBI is not necessary. Instead, attention should be paid to patients at risk for 
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persisting problems. Identification of these patients could include not only assessment of 
current symptoms, but also an individualized approach incorporating consideration of past 
medical history, medications and psychosocial situation, and capturing other pre-injury 
factors, such as coping strategies. This study did not attempt to assess personal factors. 
However, in the light of existing evidence that personal factors, such as coping strategies and 
illness perception, are associated with poor outcome (109), it would be appropriate to address 
coping strategies in future studies. 
Health care professionals should ensure that accurate written educational information is given 
to all patients, both in the ED and at other healthcare services where patients might seek help 
at later time point after injury. 
In Sweden, there is a need to develop evidence-based standardized clinical guidelines that 
should include recommendations on assessments in order to identify potential modifiable 
factors, where fatigue should be addressed and visual functions should not be overlooked. 
 
8 CONCLUSIONS 
 An early individualized educational follow-up visit offered to patients with many 
symptoms early after mTBI, at risk for persisting disability, had no effect on symptom 
level, quality of life, activity and participation 3 months after the mTBI. 
 The results of this study lend some support to previous findings that patients reporting 
no or few symptoms early after mTBI have a good outcome, and thus have low risk 
for persisting disability and no need for routine follow-up. 
 There were some transient measurable visual changes regarding convergence in 
patients with mTBI during the sub-acute period after the injury. The finding of 
association between visual symptoms and fusional vergence requires further 
evaluation. 
 The results of this study lend some support to the value of assessing different aspects 
of fatigue. At the same time, it is important to understand what aspects of fatigue 
different assessment instruments measure. We did not find a distinct association 
between visual measures and fatigue. Findings regarding associations between 
saccades and fatigue are difficult to interpret. 
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING 
De flesta som drabbas av en hjärnskakning eller lätt traumatisk hjärnskada återhämtar sig 
ganska snabbt men en del får besvär under en längre tid. I dag finns ingen gängse uppföljning 
efter en lätt traumatisk hjärnskada eller rekommenderad behandling för de personer som får 
långvariga besvär. För att undvika onödiga sjukvårdsbesök och för att åstadkomma en 
kostnadseffektiv uppföljning efter lätt traumatisk hjärnskada bör insatser riktas till personer 
som har en trolig risk för långvariga besvär. 
I en randomiserad kontrollerad multicenterstudie utvärderades en tidig intervention given till 
personer med bedömt ökad risk, baserat på symtomskattning, för långvariga besvär efter en 
lätt traumatisk hjärnskada. Patienter som bedömdes ha en hög risk för långvariga besvär 
randomiserades till interventionsgrupp eller till konventionell handläggning. Den intervention 
som gavs inkluderade förutom lugnande besked om en troligt god prognos, även en 
strukturerad anamnes, undersökning av nervstatus, och vid behov, förslag på behandling av 
besvär såsom ångest, depression eller smärta. 
Uppföljning av alla studiedeltagare skedde efter ca tre månader. Ingen effekt av den givna 
behandlingen kunde påvisas baserat på symtomskattning, påverkan på aktivitetsutförande och 
på skattning av livskvalitet. Endast få personer hade sjukskrivning som var längre än 3 
månader. De patienter som hade få symptom i tidigt skede efter hjärnskakningen, fortsatte att 
ha få symptom och hade inte heller några problem med aktiviteter i vardagen samt de 
skattade sin livskvalitet högt. Tolkningen av detta är att stratifiering efter antal symtom kan 
vara en bra modell för att identifiera personer som inte behöver någon strukturerad 
uppföljning efter lätt traumatisk hjärnskada. 
För att öka kunskapen om potentiellt behandlingsbara faktorer undersöktes visuella symtom 
och visuella funktioner samt trötthet och i test mätbar uttröttbarhet hos 15 patienter med lätt 
traumatisk hjärnskada och i två kontrollgrupper med 15 patienter som sökt på akuten med 
extremitetsskada och 15 oskadade personer. Alla deltagare undersöktes och svarade på 
frågeformulär vid två tillfällen, i tidigt skede, ca 10 dagar efter traumat och efter ca 3-4 
månader. 
Patienter med hjärnskakning hade övergående subjektiva och vissa mätbara objektiva visuella 
förändringar, samt övergående nytillkommen trötthet. Det fanns även en association mellan 
nytillkommen trötthet och i test mätbar uttröttbarhet. Dessa fynd behöver valideras i större 
studier för att kunna implementeras i omhändertagandet av patienter med lätt traumatisk 
hjärnskada. 
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